Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Short-Term Debt
$951.00K
Quarterly · Period ending: · USD

LCTX Short-Term Debt
Latest reported$951.00Kperiod ending
Latest reported$951.00Kperiod ending
LCTX Quarterly Short-Term Debt ($0.00 → $951.00K)
Quarterly short-term debt
High-resolution chart · PNG
LCTX short-term debt history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Short-Term Debt (USD) |
|---|---|
| 951,000 | |
| 865,000 | |
| 853,000 | |
| 1,066,000 | |
| 1,048,000 | |
| 1,180,000 | |
| 1,152,000 | |
| 1,137,000 | |
| 1,115,000 | |
| 1,101,000 | |
| 882,000 | |
| 936,000 | |
| 987,000 | |
| 963,000 | |
| 952,000 | |
| 568,000 | |
| 622,000 | |
| 750,000 | |
| 831,000 | |
| 818,000 | |
| 807,000 | |
| 1,309,000 | |
| 1,285,000 | |
| 1,011,000 | |
| 1,241,000 | |
| 1,240,000 | |
| 1,223,000 | |
| 1,138,000 | |
| 956,000 | |
| 972,000 | |
| 307,000 | |
| 301,000 | |
| 345,000 | |
| 342,000 | |
| 364,000 | |
| 139,000 | |
| 2,679,000 | |
| 1,194,000 | |
| 1,134,000 | |
| 625,000 | |
| 268,000 | |
| 117,000 | |
| 133,000 | |
| 396,000 | |
| 296,000 | |
| 227,408 | |
| 58,000 | |
| 60,588 | |
| 57,500 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 135,455 | |
| 3,314,033 | |
| 0 | |
| 0 | |
| 2,690,698 | |
| 1,924,156 | |
| 1,307,328 | |
| 716,537 | |
| 353,931 | |
| 306,370 | |
| 100,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 2,685,392 | |
| 2,454,154 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 3,350,000 |